Related Experiment Video
Updated: Jul 12, 2025

06:54
Author Spotlight: Advancements in Impedance Monitoring for Cochlear Implant Surgery
Published on: August 4, 2023
1.2K
Surgical Versus Noninvasive Manual Repositioning After Cochlear Implant Partial Magnet Dislocation
Robin Rupp1, Matthias Balk1, Moritz Allner1
1Department of Otorhinolaryngology, Head and Neck Surgery, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Ear, Nose, & Throat Journal
|October 21, 2023
Summary
Noninvasive manual magnet repositioning (MMR) is highly successful for cochlear implant (CI) magnet dislocation, offering shorter downtime and fewer complications than surgical magnet repositioning (SMR). MMR should be the first-line treatment for CI patients experiencing partial magnet dislocation.
Area of Science:
- Otolaryngology
- Neurosurgery
- Medical Imaging
Background:
- Partial magnet dislocation (PMD) of the internal magnet in cochlear implants (CI) can occur after magnetic resonance imaging (MRI).
- Treatment options for PMD include surgical magnet repositioning (SMR) and noninvasive manual magnet repositioning (MMR).
Purpose of the Study:
- To compare the success rates, CI downtime, and complication rates of SMR and MMR for treating PMD in CI patients.
- To determine the optimal treatment strategy for PMD caused by MRI.
Main Methods:
- A single-center retrospective study included 51 cases of PMD in 42 CI patients treated between 2007 and 2022.
- SMR was the primary treatment until June 2019, after which MMR was introduced as a primary or secondary treatment.
Main Results:
- MMR demonstrated a high success rate (95% in 20 cases), while SMR was successful in 32 cases.
- MMR resulted in significantly shorter times from diagnosis to treatment, repositioning to CI reactivation, and total CI downtime compared to SMR.
- MMR was associated with significantly fewer complications (0%) compared to SMR (25%).
Conclusions:
- Noninvasive MMR is a highly effective treatment for PMD in CI patients, offering superior outcomes to SMR.
- MMR should be considered the first-line treatment for MRI-induced PMD, with SMR reserved for cases where MMR fails.

